Growing Immunization Campaigns to Play Vital Role in Driving the Global Typhoid Vaccines Market during 2017-2025
Rising prevalence of typhoid, increasing investments from companies operating in the market and growing immunization campaigns across the world will fuel the growth .
Rising prevalence of typhoid, increasing investments from companies operating in the market and growing immunization campaigns across the world will fuel the growth of the global typhoid vaccines market during the forecast period, i.e., 2017 to 2025, says a new report published by Transparency Market Research.
According to the report, the global typhoid vaccines market can be classified in accordance with product, mode of administration, distribution channel, and end-user. The market is classified into four types in terms of product, and these are Ty21a, Vi capsular polysaccharide vaccine, Vi Conjugate (Vi-TT), and Vi Conjugate (Vi-REPA).
Download Free Sample Report on: - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37556
Amongst these, Vi capsular polysaccharide is a sub-unit vaccine while Ty21a is a live vaccine. The other two types i.e., Vi Conjugate (Vi-TT), and Vi Conjugate (Vi-REPA) are constrained to the private sector and do not have worldwide acceptance. Vi Conjugate (Vi-TT), for instance, is licensed only for the market in India.
The typhoid vaccines market can be further segmented into injectable or oral. Vi capsular polysaccharide vaccine for example is injectable, while Ty21a is taken orally. The major players operating in the global typhoid vaccines market are included in this report and those are GlaxoSmithKline plc, Merck & Co. Inc., AstraZeneca, Pfizer, Inc., Sanofi, and Johnson & Johnson.
The information presented above is based on the TMR’s research report, titled, “Typhoid Vaccines Market (Product – Ty21a, Vi Conjugate (Vi-TT), Vi capsular polysaccharide vaccine, and Vi Conjugate (Vi-REPA); Mode of Administration – Oral and Injectable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
According to the report, the global typhoid vaccines market can be classified in accordance with product, mode of administration, distribution channel, and end-user. The market is classified into four types in terms of product, and these are Ty21a, Vi capsular polysaccharide vaccine, Vi Conjugate (Vi-TT), and Vi Conjugate (Vi-REPA).
Download Free Sample Report on: - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37556
Amongst these, Vi capsular polysaccharide is a sub-unit vaccine while Ty21a is a live vaccine. The other two types i.e., Vi Conjugate (Vi-TT), and Vi Conjugate (Vi-REPA) are constrained to the private sector and do not have worldwide acceptance. Vi Conjugate (Vi-TT), for instance, is licensed only for the market in India.
The typhoid vaccines market can be further segmented into injectable or oral. Vi capsular polysaccharide vaccine for example is injectable, while Ty21a is taken orally. The major players operating in the global typhoid vaccines market are included in this report and those are GlaxoSmithKline plc, Merck & Co. Inc., AstraZeneca, Pfizer, Inc., Sanofi, and Johnson & Johnson.
The information presented above is based on the TMR’s research report, titled, “Typhoid Vaccines Market (Product – Ty21a, Vi Conjugate (Vi-TT), Vi capsular polysaccharide vaccine, and Vi Conjugate (Vi-REPA); Mode of Administration – Oral and Injectable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
- Contact Email
- [email protected]
- Issued By
- Transparency Market Research
- Phone
- 5186181030
- Business Address
- State Tower, 90 State Street, Suite 700,
- Country
- United States
- Categories
- Marketing · News
- Last Updated
- December 17, 2018